174eP Progesterone receptor expression and endocrine therapy outcomes in low-grade serous ovarian carcinoma
Low-grade serous ovarian carcinoma (LGSOC) is characterized by relative chemoresistance and frequent hormone receptor expression. Endocrine therapy is used in selected settings; however, no biomarker is available to guide patient selection. We evaluated the association between progesterone receptor (PR) expression and endocrine therapy outcomes and its relationship with estrogen receptor (ER) levels.
Authors
- N. Ak
- S. Bagbudar
- D.E. Yüksekli
- B.A. Zengin
- M. Ugar
- A. Toyran
- P.M. Saip
Institutions
- University Hospital of Bern (CH)
- Universitätsklinik für Neurologie (AT)
- Istanbul University (TR)
Publication Details
- Journal
- ESMO Open
- Published
- 2026-07-01
- DOI
- https://doi.org/10.1016/j.esmoop.2026.108221
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00